COPM-Based Goal Setting Strategies in the PICU
Launched by SAMSUNG MEDICAL CENTER · Aug 13, 2025
Trial Information
Current as of September 06, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to set personalized care goals for children in the Pediatric Intensive Care Unit (PICU) using a tool called the Canadian Occupational Performance Measure (COPM). The goal is to improve communication and teamwork between healthcare providers and families, helping to focus on what matters most for each child’s recovery while they are critically ill. The study is still in the early stages and is not yet enrolling participants.
Families who might be involved include legal guardians of children aged 1 to 18 years who have been in the PICU for at least a day. Healthcare professionals such as doctors, nurses, occupational therapists, and physical therapists with experience in pediatric intensive care will also take part in earlier parts of the study to help develop and test these goal-setting strategies. If you participate, you can expect to be involved in discussions about your child’s care goals and work closely with the care team to tailor the treatment plan. It’s important to note that caregivers need to speak Korean and be emotionally ready to take part, and everyone’s privacy and choices will be respected throughout the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Phase 1-2 (Delphi Survey - Experts)
- • Physicians specializing in pediatrics or physical medicine and rehabilitation, occupational therapists, physical therapists, and nursing staff
- • Minimum of 2 years of direct clinical experience in a Pediatric Intensive Care Unit (PICU)
- • Phase 3 (Pilot Testing - Caregivers \& PICU Clinicians)
- Caregivers:
- • Legal guardian of a child aged 1-18 years admitted to PICU
- • ≥24 hours post-admission
- PICU clinicians:
- • - Treating occupational or physical therapist involved in the child's care during PICU admission
- Exclusion Criteria:
- • Phase 1-2 (Delphi Survey - Experts)
- • Rehabilitation professionals without prior PICU clinical experience
- • Inability to read or respond to Korean-language surveys
- • Phase 3 (Pilot Testing - Caregivers \& PICU Clinicians)
- • Caregivers experiencing severe emotional distress, or deemed inappropriate for participation by the treating clinician
- • Non-Korean-speaking caregivers
- • Refusal or withdrawal of informed consent at any stage
About Samsung Medical Center
Samsung Medical Center (SMC) is a leading healthcare institution in South Korea, renowned for its commitment to advancing medical research and innovation. As a prominent clinical trial sponsor, SMC integrates cutting-edge technology and expert clinical practices to conduct rigorous studies aimed at improving patient outcomes. The center is dedicated to fostering collaborations with global research entities and adhering to the highest ethical standards, ensuring the integrity and reliability of its clinical trials. With a focus on diverse therapeutic areas, SMC plays a pivotal role in translating scientific discoveries into effective treatments, ultimately enhancing the quality of healthcare worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported